ous veins: 36-month
outcomes of the VeClose randomized controlled trial. Phlebology
2019;34:380-90.
179. Morrison N, Gibson K, Vasquez M, Weiss R, Cher D, Madsen M, et al.
VeClose trial 12-month outcomes of cyanoacrylate closure versus
radiofrequency ablation for incompetent great saphenous veins.
J Vasc Surg